US Stock MarketDetailed Quotes

GOSS Gossamer Bio

Watchlist
  • 1.170
  • +0.010+0.86%
Close Mar 28 16:00 ET
  • 1.150
  • -0.020-1.71%
Post 20:01 ET
265.85MMarket Cap-4.68P/E (TTM)

Gossamer Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
97.82%-3.47M
-6.15%-35.48M
7.13%-32.03M
404.17%116.35M
1.30%-52.3M
14.90%-159.16M
29.97%-33.42M
6.77%-34.49M
21.65%-38.25M
0.92%-52.99M
Net income from continuing operations
68.56%-56.53M
31.40%-33.03M
23.01%-30.8M
215.85%49.23M
14.72%-41.93M
21.61%-179.82M
13.66%-48.15M
32.60%-40.01M
24.74%-42.5M
14.92%-49.17M
Operating gains losses
11.02%806K
--185K
--305K
--0
--316K
--726K
--0
----
----
----
Depreciation and amortization
-5.34%4.15M
6.86%1.08M
0.92%1.1M
-13.81%992K
-13.51%986K
-0.99%4.39M
-10.42%1.01M
-1.98%1.09M
4.73%1.15M
3.92%1.14M
Other non cash items
-90.41%1.09M
-97.69%238K
-20.14%234K
-9.07%321K
-20.16%293K
821.91%11.32M
3,516.84%10.31M
-7.57%293K
12.42%353K
17.63%367K
Change In working capital
365.89%39.46M
-678.23%-5.55M
-5,361.04%-4.05M
1,714.65%63.8M
-23.53%-14.73M
-232.83%-14.84M
126.09%960K
-99.31%77K
-4.30%-3.95M
-45.19%-11.93M
-Change in receivables
---5.34M
--1.25M
---2.96M
----
----
--0
--0
--0
----
----
-Change in prepaid assets
101.59%62K
-75.52%614K
258.28%2.14M
29.04%-1.91M
66.84%-781K
-1,414.86%-3.89M
73.32%2.51M
-147.08%-1.35M
-87.80%-2.69M
9.04%-2.36M
-Change in payables and accrued expense
-1.28%-8.13M
322.39%1.81M
-84.86%312K
691.45%2.9M
-49.74%-13.16M
-229.87%-8.03M
81.46%-813K
-75.48%2.06M
66.18%-491K
-75.58%-8.79M
-Change in other current assets
440.32%335K
--0
-285.12%-224K
2,151.85%554K
107.94%5K
-84.50%62K
160.78%31K
-80.64%121K
88.51%-27K
-203.28%-63K
-Change in other current liabilities
-13.55%-3.39M
-35.12%-1.04M
2.92%-731K
-10.68%-819K
-10.79%-801K
-9.59%-2.98M
-10.85%-766K
-10.74%-753K
-10.94%-740K
-5.86%-723K
-Change in other working capital
--55.92M
---8.19M
---2.59M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
97.82%-3.47M
-6.15%-35.48M
7.13%-32.03M
404.17%116.35M
1.30%-52.3M
14.90%-159.16M
29.97%-33.42M
6.77%-34.49M
21.65%-38.25M
0.92%-52.99M
Investing cash flow
Cash flow from continuing investing activities
126.15%29.02M
470.43%53.22M
77.38%-26.75M
-556.96%-59.11M
607.10%61.67M
-10,621.74%-110.97M
-269.73%-14.37M
-423.33%-118.26M
176.47%12.94M
3.59%8.72M
Net PPE purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net intangibles purchase and sale
--0
----
----
--0
--0
--0
----
----
0.00%-15K
25.00%-15K
Net investment purchase and sale
126.15%29.02M
470.43%53.22M
77.38%-26.75M
-556.43%-59.11M
605.88%61.67M
-19,716.07%-110.97M
-267.42%-14.37M
-424.53%-118.29M
169.03%12.95M
1.63%8.74M
Cash from discontinued investing activities
Investing cash flow
126.15%29.02M
470.43%53.22M
77.38%-26.75M
-556.96%-59.11M
607.10%61.67M
-10,621.74%-110.97M
-269.73%-14.37M
-423.33%-118.26M
176.47%12.94M
3.59%8.72M
Financing cash flow
Cash flow from continuing financing activities
-106.04%-11.49M
0
-99.86%281K
-217.29%-9.21M
-0.75%-2.56M
62.40%190.15M
-1.04%-2.9M
66.49%198.5M
-13,928.57%-2.9M
-451.73%-2.54M
Net issuance payments of debt
-8.34%-12.58M
--0
--0
-233.26%-9.68M
0.00%-2.9M
-100.02%-11.61M
0.00%-2.9M
0.00%-2.9M
---2.9M
---2.9M
Net common stock issuance
--0
--0
----
----
----
67.84%201.32M
--0
----
----
----
Proceeds from stock option exercised by employees
146.17%1.09M
--464K
264.94%281K
--0
-5.18%348K
-84.95%444K
--0
-96.49%77K
--0
-49.10%367K
Net other financing activities
----
----
--0
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-106.04%-11.49M
--0
-99.86%281K
-217.29%-9.21M
-0.75%-2.56M
62.40%190.15M
-1.04%-2.9M
66.49%198.5M
-13,928.57%-2.9M
-451.73%-2.54M
Net cash flow
Beginning cash position
-71.32%32.11M
-65.54%28.46M
134.78%86.88M
-40.43%38.86M
-71.32%32.11M
-38.97%111.97M
-46.17%82.61M
-60.77%37M
-53.05%65.24M
-38.97%111.97M
Current changes in cash
117.59%14.07M
134.99%17.74M
-227.91%-58.51M
270.18%48.02M
114.56%6.82M
-12.68%-79.97M
-20.30%-50.69M
-23.29%45.74M
36.04%-28.22M
-5.55%-46.8M
Effect of exchange rate changes
-192.73%-102K
-164.77%-125K
168.38%93K
57.89%-8K
-186.11%-62K
121.28%110K
-69.61%193K
70.75%-136K
96.44%-19K
146.75%72K
End cash Position
43.49%46.07M
43.49%46.07M
-65.54%28.46M
134.78%86.88M
-40.43%38.86M
-71.32%32.11M
-71.32%32.11M
-46.17%82.61M
-60.77%37M
-53.05%65.24M
Free cash flow
97.82%-3.47M
-6.15%-35.48M
7.05%-32.03M
404.05%116.35M
1.32%-52.3M
15.12%-159.16M
30.14%-33.42M
6.96%-34.46M
21.84%-38.27M
1.22%-53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 97.82%-3.47M-6.15%-35.48M7.13%-32.03M404.17%116.35M1.30%-52.3M14.90%-159.16M29.97%-33.42M6.77%-34.49M21.65%-38.25M0.92%-52.99M
Net income from continuing operations 68.56%-56.53M31.40%-33.03M23.01%-30.8M215.85%49.23M14.72%-41.93M21.61%-179.82M13.66%-48.15M32.60%-40.01M24.74%-42.5M14.92%-49.17M
Operating gains losses 11.02%806K--185K--305K--0--316K--726K--0------------
Depreciation and amortization -5.34%4.15M6.86%1.08M0.92%1.1M-13.81%992K-13.51%986K-0.99%4.39M-10.42%1.01M-1.98%1.09M4.73%1.15M3.92%1.14M
Other non cash items -90.41%1.09M-97.69%238K-20.14%234K-9.07%321K-20.16%293K821.91%11.32M3,516.84%10.31M-7.57%293K12.42%353K17.63%367K
Change In working capital 365.89%39.46M-678.23%-5.55M-5,361.04%-4.05M1,714.65%63.8M-23.53%-14.73M-232.83%-14.84M126.09%960K-99.31%77K-4.30%-3.95M-45.19%-11.93M
-Change in receivables ---5.34M--1.25M---2.96M----------0--0--0--------
-Change in prepaid assets 101.59%62K-75.52%614K258.28%2.14M29.04%-1.91M66.84%-781K-1,414.86%-3.89M73.32%2.51M-147.08%-1.35M-87.80%-2.69M9.04%-2.36M
-Change in payables and accrued expense -1.28%-8.13M322.39%1.81M-84.86%312K691.45%2.9M-49.74%-13.16M-229.87%-8.03M81.46%-813K-75.48%2.06M66.18%-491K-75.58%-8.79M
-Change in other current assets 440.32%335K--0-285.12%-224K2,151.85%554K107.94%5K-84.50%62K160.78%31K-80.64%121K88.51%-27K-203.28%-63K
-Change in other current liabilities -13.55%-3.39M-35.12%-1.04M2.92%-731K-10.68%-819K-10.79%-801K-9.59%-2.98M-10.85%-766K-10.74%-753K-10.94%-740K-5.86%-723K
-Change in other working capital --55.92M---8.19M---2.59M----------------------------
Cash from discontinued investing activities
Operating cash flow 97.82%-3.47M-6.15%-35.48M7.13%-32.03M404.17%116.35M1.30%-52.3M14.90%-159.16M29.97%-33.42M6.77%-34.49M21.65%-38.25M0.92%-52.99M
Investing cash flow
Cash flow from continuing investing activities 126.15%29.02M470.43%53.22M77.38%-26.75M-556.96%-59.11M607.10%61.67M-10,621.74%-110.97M-269.73%-14.37M-423.33%-118.26M176.47%12.94M3.59%8.72M
Net PPE purchase and sale --0------------------0----------------
Net intangibles purchase and sale --0----------0--0--0--------0.00%-15K25.00%-15K
Net investment purchase and sale 126.15%29.02M470.43%53.22M77.38%-26.75M-556.43%-59.11M605.88%61.67M-19,716.07%-110.97M-267.42%-14.37M-424.53%-118.29M169.03%12.95M1.63%8.74M
Cash from discontinued investing activities
Investing cash flow 126.15%29.02M470.43%53.22M77.38%-26.75M-556.96%-59.11M607.10%61.67M-10,621.74%-110.97M-269.73%-14.37M-423.33%-118.26M176.47%12.94M3.59%8.72M
Financing cash flow
Cash flow from continuing financing activities -106.04%-11.49M0-99.86%281K-217.29%-9.21M-0.75%-2.56M62.40%190.15M-1.04%-2.9M66.49%198.5M-13,928.57%-2.9M-451.73%-2.54M
Net issuance payments of debt -8.34%-12.58M--0--0-233.26%-9.68M0.00%-2.9M-100.02%-11.61M0.00%-2.9M0.00%-2.9M---2.9M---2.9M
Net common stock issuance --0--0------------67.84%201.32M--0------------
Proceeds from stock option exercised by employees 146.17%1.09M--464K264.94%281K--0-5.18%348K-84.95%444K--0-96.49%77K--0-49.10%367K
Net other financing activities ----------0----------------------------
Cash from discontinued financing activities
Financing cash flow -106.04%-11.49M--0-99.86%281K-217.29%-9.21M-0.75%-2.56M62.40%190.15M-1.04%-2.9M66.49%198.5M-13,928.57%-2.9M-451.73%-2.54M
Net cash flow
Beginning cash position -71.32%32.11M-65.54%28.46M134.78%86.88M-40.43%38.86M-71.32%32.11M-38.97%111.97M-46.17%82.61M-60.77%37M-53.05%65.24M-38.97%111.97M
Current changes in cash 117.59%14.07M134.99%17.74M-227.91%-58.51M270.18%48.02M114.56%6.82M-12.68%-79.97M-20.30%-50.69M-23.29%45.74M36.04%-28.22M-5.55%-46.8M
Effect of exchange rate changes -192.73%-102K-164.77%-125K168.38%93K57.89%-8K-186.11%-62K121.28%110K-69.61%193K70.75%-136K96.44%-19K146.75%72K
End cash Position 43.49%46.07M43.49%46.07M-65.54%28.46M134.78%86.88M-40.43%38.86M-71.32%32.11M-71.32%32.11M-46.17%82.61M-60.77%37M-53.05%65.24M
Free cash flow 97.82%-3.47M-6.15%-35.48M7.05%-32.03M404.05%116.35M1.32%-52.3M15.12%-159.16M30.14%-33.42M6.96%-34.46M21.84%-38.27M1.22%-53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.